Consider the impact of spinal cord injury and the potential scope of lifetime disability and sequelae associated with spinal cord injury. The greatest challenge facing the neuroscience community involves developing therapy that will allow damaged nerve tissue to be regrown and regenerated.

Consider the impact of spinal cord injury and the potential scope of lifetime disability and sequelae associated with spinal cord injury. The greatest challenge facing the neuroscience community involves developing therapy that will allow damaged nerve tissue to be regrown and regenerated.

Read chapters 15 – 20 in the course text

 

1. Compose at least 2-3 paragraphs all in APA format for each with proper references

2. use link provided with account info below

3.

4. https://online.vitalsource.com/reader/books/9780323088541/epubcfi/6/2[idloc_000.xhtml-itemref]!/4[eid1]/8[eid5]/6[eid8]/1:41[%5E%2C%20U%2Cniv]

 

Week 3 Discussion Forum Prompt 1

Select one of the following discussion prompts to address:

· Consider the impact of spinal cord injury and the potential scope of lifetime disability and sequelae associated with spinal cord injury. The greatest challenge facing the neuroscience community involves developing therapy that will allow damaged nerve tissue to be regrown and regenerated. Reflect on this article

· Links to an external site. and discuss the importance of Schwann cells and their impact on damaged axons.

· Describe the genetic components, pathophysiology, and major neurologic features of neurofibromatosis, Cri du chat syndrome, Tay-Sachs disease, and Parkinson disease (early onset).

· Define dementia of Alzheimer type (DAT) and describe the pathophysiology, clinical manifestations, evaluation and treatment.

Use at least one scholarly source other than your textbook to connect your response to national guidelines and evidence-based research in support of your ideas.

 

 

 

 

 

 

Week 3 Discussion Forum Prompt 2

Select one of the following discussion prompts to address:

· Consider the following scenario: Your patient has suffered from schizophrenia for two decades and has received classic dopaminergic treatments since the onset of illness. The latest research supporting use of the glutamatergic model has not been tried on your patient, and there is an opportunity for your patient to enter clinical trials utilizing glutamate-based treatments. Your patient suffers significant executive function impairment and memory impairment. Do you recommend participation in the clinical trial? Why or why not?

· Discuss the pathophysiology of cerebrovascular accidents (CVAs)—thrombotic, embolic, hemorrhagic, and lacunar—their incidence and prevalence, clinical manifestations, evaluation, and treatment.

· Discuss the characteristics of common headaches—migraine, cluster, and tension—and describe their evaluation and treatment options. What prevention strategies would you advise?

Use at least one scholarly source other than your textbook to connect your response to national guidelines and evidence-based research in support of your ideas.